相关实验视频
Updated: Jun 4, 2025

07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
32.9K
关于奎平对鼠认知功能和突触可塑性的保护作用的机制性见解
Yanping Lan1, Ao Li2, Chenzhe Ding1
1Ningxia Clinical Research Institute, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, PR China.
Brain research
|December 27, 2024
概括
氨酸通过激活CREB/BDNF通路并增强突触可塑性,改善了性老鼠的学习和记忆. 这种非典型的抗精神病药物也抑制了MMP-9的表达,提供神经保护的好处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与认知缺陷和突触可塑性改变有关.
- 奎蒂亚平是一种非典型的抗精神病药物,具有潜在的神经保护性.
- CREB/BDNF通路和MMP-9与突触功能和有关.
研究的目的:
- 为了研究奎蒂亚平对鼠模型中的认知功能和突触可塑性的影响.
- 阐明涉及CREB/BDNF通路和MMP-9表达的潜在机制.
主要方法:
- 在老鼠中使用皮洛卡诱导了.
- 奎蒂亚平或盐水给了性老鼠.
- 行为测试评估了学习,记忆和空间探索.
- 西方斑块,免疫组织化学和免疫光分析了蛋白质表达和通路活性.
主要成果:
- 奎蒂亚平显著改善了性大鼠的学习和记忆.
- 奎蒂阿平在海马体上调节了亲BDNF,成熟的BDNF,p-CREB和CREB.
- 奎平抑制了MMP-9表达和增加了突触可塑性标记物 (SYN,PSD-95).
结论:
- 奎蒂亚平可以增强性老鼠的认知功能.
- 奎平激活了CREB/BDNF信号通路.
- 奎平通过调节突触可塑性和抑制MMP-9来产生神经保护作用.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
245
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
245
Antiepileptic Drugs: GABAergic Pathway Potentiators
325
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
325
Antiepileptic Drugs: Potassium Channel Activators
143
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
143
Antiepileptic Drugs: Glutamate Antagonists
280
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
280
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: Calcium Channel Blockers
313
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
313

